Chicago-based Northwestern Medicine will be the first site for Clarion's Clarity trial for spine surgery, according to a Feb. 6 news release.

Northwestern Medicine is a global leader in clinical trial research, including spineCLARITY is a randomized study designed to demonstrate ...

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...

Aclarion stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company, announced today that it has raised nearly $20 million in gross proceeds since January 1, 2025. This funding ...

Aclarion (ACON) has secured full funding for its pivotal CLARITY trial which is designed to demonstrate Nociscan’s clinical and economic value ...

Chief Strategy Officer Ryan Bond stated, "This milestone ensures we reach the study's conclusion, potentially unlocking broad ...

Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company with a market capitalization of ...

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

The reverse stock split will not change the authorized number of shares of the Company’s common stock. No fractional shares will be issued and any fractional shares resulting from the reverse stock ...